-
Crude prices surge, stocks sink amid rising energy shock fears
-
Kings of K-pop: What to know about BTS's comeback
-
Patching the wounds of Kinshasa's street children
-
Thailand's Anutin: Millionaire PM with a populist approach
-
In Seoul square of protest and history, BTS fans welcome grand comeback
-
Hong Kong panel hears safety measures failed on day of deadly fire
-
Trump threatens to destroy Iran's largest gas field
-
Doncic and James power Lakers over Rockets as win streak hits seven
-
Inter continue Serie A title hunt ahead of Italy's date with World Cup destiny
-
Strait of Hormuz blockage drives up Gulf food bills
-
Ahead of election, Danish city mirrors country's challenges
-
Wild possum shelters with plush toys in Australian airport shop
-
Iran missile fire kills 3 Palestinians in West Bank, foreign worker in Israel
-
Asian Games cruise ship and wooden huts will be 'unique experience'
-
Pacific nations fear fuel shortages as Middle East war sends oil prices soaring
-
World indoor athletics championships: five stand-out events
-
Crude prices surge, stocks sink as Iran warns of regional energy strikes
-
'No oil, no money': Orban brings Ukraine standoff to Brussels
-
Mideast energy shock rattles eurozone rate-setters
-
Scotland's Laidlaw extends tenure as Hurricanes coach
-
Messi scores 900th career goal but Miami crash out
-
Japan coach says Australia 'massive favourites' in Asian Cup final
-
Iran targets Gulf energy sites after gas field strike
-
Director plans to put Val Kilmer back on screen thanks to AI
-
Social media addiction trial jury deliberations continue
-
Messi scores 900th career goal in Inter Miami cup clash
-
Barcelona, Liverpool, Bayern and Atletico reach Champions League quarter-finals
-
Tudor impressed by 'improved' Spurs despite Champions League exit
-
PSG will not relish Liverpool reunion, says Slot
-
Kane says Bayern 'don't fear anyone' ahead of Real clash
-
Venezuelan leader sacks defense minister, a Maduro stalwart
-
Kane and Bayern swat aside Atalanta to set up Real clash
-
Thailand's new parliament set to elect Anutin as PM
-
Atletico survive Spurs scare to reach Champions League quarters
-
Liverpool thrash Galatasaray to reach Champions League quarters
-
Music popstar will.i.am meshes AI and 'micromobility'
-
US Fed Chair says 'no intention' of leaving board while probe ongoing
-
US stocks fall on latest oil price surge as Fed lifts inflation forecast
-
Iran targets Gulf energy sites after intel chief killed
-
Costa Rica closes Havana embassy, tells Cuba to withdraw diplomats
-
NY's New Museum returns contemporary to heart of Manhattan
-
Cesar Chavez, icon of US labor movement, accused of serial sex abuse: report
-
Barcelona demolish Newcastle 7-2 to reach Champions League quarters
-
US Fed raises inflation outlook over 'uncertain' Iran war impact
-
Trump nominee for Homeland Security chief grilled at fiery Senate hearing
-
First international aid convoy arrives in crisis-hit Cuba
-
Eight killed during Rio police operation, including drug kingpin
-
Iran suffers new blow as Israel kills intel chief
-
Slovakia curbs diesel sales, ups prices for foreigners
-
Oscar-winner Sean Penn meets troops in frontline Ukraine
Court to hear lawsuit seeking to ban abortion pill in US
A Texas judge favored by anti-abortion activists will hear arguments Wednesday in an unprecedented challenge to the legality of a widely-used abortion pill.
US District Court Judge Matthew Kacsmaryk announced Monday the hearing on a lawsuit alleging the US Food and Drug Administration (FDA) should never have approved the "dangerous" prescription drug Mifepristone in 2000.
Mifepristone, one component of a two-drug regimen used for medication abortion, has been used by an estimated 5.6 million women to terminate pregnancies since its approval, according to the FDA.
It is can be used in the United States up to 10 weeks of pregnancy.
The pro-abortion rights Guttmacher Institute estimates that more than half of all abortions involve the use of mifepristone.
But the Alliance Defending Freedom, a Christian advocacy group, sued the FDA saying its approval "disavow(ed)" science, "ignored" potential health impacts and "disregarded" the complications that can arise with using mifepristone.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Galvanized by the Supreme Court's ruling in June that overturned the constitutional right to an abortion, abortion opponents have now set their sights on obtaining prohibitions on mifepristone.
Already the treatment has been halted in some 15 states which have banned all abortion since the 2022 Supreme Court decision.
The Texas suit seeks to block it nationally by overturning the FDA's approval of the drug.
The FDA has urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
Kacsmaryk was targeted by the plaintiffs to hear the case due to his deep conservative Christian beliefs and previous anti-abortion stance.
He had been expected since February 24 to issue a ruling in the case, which asks him to suspend the FDA's approval of the drug while the lawsuit proceeds.
Apparently fearing protestors descending on the courthouse in Amarillo, Texas, Kacsmaryk originally sought to keep the hearing secret until the last minute, but it leaked to media.
If he does order the suspension, it could leave pregnant women with the alternative of using only misoprostol, the second pill in the medication abortion treatment.
But using misoprostol alone is more physically traumatic than the two-pill procedure, and some fear doctors might be unwilling to prescribe it alone.
If mifepristone is banned, "access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
O.Bulka--BTB